ORBIMED ADVISORS LLC sold 8.8% of their position (583.66K shares) of PASSAGE BIO, INC. on the open market
Open‑market sale worth $197.2K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 3 sales
Filed: 6/26/2025ACC: 0000947871-25-000629
-583.66K
Net shares
Net seller
$197.2K
Total sold
3
Open market trades
0B · 3S
3
Total transactions
583.66K disposed
Non-Derivative Transactions3
Common Stock
Indirect
Shares
−231.60K
Price / share
$0.35
Trade value
$81.06K
% of position
3.5%
6/24/2025
6.65M→6.42M
Common Stock
Indirect
Shares
−138.80K
Price / share
$0.33
Trade value
$45.80K
% of position
2.2%
6/25/2025
6.42M→6.28M
Common Stock
Indirect
Shares
−213.26K
Price / share
$0.33
Trade value
$70.37K
% of position
3.4%
6/26/2025
6.28M→6.07M
Total
Net shares
−583.66K
Net value
-$197.24K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 6/24/2025 | S · Sale | −231.60K | $0.35 | $81.06K | 3.5% | 6.65M | 6.42M |
| Common Stock Indirect | 6/25/2025 | S · Sale | −138.80K | $0.33 | $45.80K | 2.2% | 6.42M | 6.28M |
| Common Stock Indirect | 6/26/2025 | S · Sale | −213.26K | $0.33 | $70.37K | 3.4% | 6.28M | 6.07M |
| Total | −583.66K | -$197.24K | ||||||
Derivative Transactions0
No derivative transactions reported